From Wikipedia, the free encyclopedia
Jump to: navigation, search
Systematic (IUPAC) name
3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
Clinical data
Trade names Starlix
AHFS/ monograph
MedlinePlus a699057
Licence data EMA:Link, US FDA:link
Legal status
Routes Oral
Pharmacokinetic data
Protein binding 98%
Half-life 1.5 hours
CAS number 105816-04-4 YesY
ATC code A10BX03
PubChem CID 60026
DrugBank DB00731
ChemSpider 10482084 YesY
KEGG D01111 N
Chemical data
Formula C19H27NO3 
Mol. mass 317.423 g/mol
 N (what is this?)  (verify)

Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis.

Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs.


Nateglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the β cells. This depolarizes the β cells and causes voltage-gated calcium channels to open. The resulting calcium influx induces fusion of insulin-containing vesicles with the cell membrane, and insulin secretion occurs.


Nateglinide is contraindicated in patients who:

Comparisons with other drugs for type 2 diabetes[edit]

A study funded by Novo Nordisk, the U.S. distributor for Repaglinide, compared their product with Nateglinide in "A randomized, parallel-group, open-label, multicenter 16-week clinical trial".[1] They concluded that the two were similar, but "repaglinide monotherapy was significantly more effective than nateglinide monotherapy in reducing HbA1c and FPG values after 16 weeks of therapy."


Nateglinide is delivered in 60 mg & 120 mg tablet form.


  1. ^ Rosenstock, Julio Rosenstock; Hassman, David R.; Madder, Robert D.; Brazinsky, Shari A.; Farrell, James; Khutoryansky, Naum; Hale, Paula M. (June 2004), "Repaglinide Versus Nateglinide Monotherapy: A randomized, multicenter study", Diabetes Care (American Diabetes Association) 27 (6): 1265–1270, retrieved 2014-11-20 

External links[edit]